Iksuda

is an England-based biotechnology company that develops and commercializes antibody therapies for the treatment of cancer...
Read more
Iksuda Co-Founder & CEO: David Simpson

Co-Founder & CEO

David Simpson

CEO Approval Rating

90/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$72.8M

Iksuda Competitors

1OBT
2NBE Therapeutics
3Tubulis
4ADC Therapeutics
5CytomX
6ADC Bio
7Calypso Biotech
8Glycostem
9Paragon Gene
10Glycotope

Trending Companies